Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    NCT00298337
Previous Study | Return to List | Next Study

Use of Probiotic Bacteria in Prevention of Allergic Disease in Children 1999-2008

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00298337
Recruitment Status : Unknown
Verified March 2006 by University of Helsinki.
Recruitment status was:  Active, not recruiting
First Posted : March 2, 2006
Last Update Posted : October 18, 2006
Sponsor:
Information provided by:
University of Helsinki

Brief Summary:
The aim of the study is to find out if allergic diseases can be prevented buy giving probiotic bacteria to pregnant mothers and their newborn infants

Condition or disease Intervention/treatment Phase
Atopic Dermatitis Food Hypersensitivity Allergic Rhinitis, Seasonal Allergic Conjunctivitis Asthma Drug: Mixture of probiotic bacteria and prebiotic oligosaccharide Phase 2 Phase 3

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double
Primary Purpose: Prevention
Study Start Date : October 1999
Study Completion Date : December 2007

Resource links provided by the National Library of Medicine






Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   37 Weeks to 42 Weeks   (Child)
Sexes Eligible for Study:   All
Criteria

Inclusion Criteria:

  • mother or father fo child with doctor diagnoses allergic disease

Exclusion Criteria:

  • prematurity, major malformations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00298337


Locations
Layout table for location information
Finland
Helsinki University Central Hospital, Skin and Allergy Hospital
Helsinki, PO box 160, Finland, 00029 HUS
Sponsors and Collaborators
University of Helsinki
Investigators
Layout table for investigator information
Study Chair: Erkki Savilahti, Professor Helsinki University Central Hospital, Hospital for Children and Adults, PO Box 281, 00029 HUS, Finland
Additional Information:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
ClinicalTrials.gov Identifier: NCT00298337    
Other Study ID Numbers: T101060058;T1040A0002;T110612
First Posted: March 2, 2006    Key Record Dates
Last Update Posted: October 18, 2006
Last Verified: March 2006
Additional relevant MeSH terms:
Layout table for MeSH terms
Rhinitis
Rhinitis, Allergic
Rhinitis, Allergic, Seasonal
Conjunctivitis
Conjunctivitis, Allergic
Dermatitis, Atopic
Dermatitis
Hypersensitivity
Food Hypersensitivity
Skin Diseases
Nose Diseases
Respiratory Tract Diseases
Respiratory Tract Infections
Otorhinolaryngologic Diseases
Skin Diseases, Genetic
Genetic Diseases, Inborn
Skin Diseases, Eczematous
Hypersensitivity, Immediate
Immune System Diseases
Respiratory Hypersensitivity
Conjunctival Diseases
Eye Diseases